The user facility reported to terumo cardiovascular that white bits on surface of the blood were observed.It is unknown when the event occurred, if there was a delay in the procedure, if the product was changed out, the results of the procedure or if there was any blood loss.
|
This follow-up report is submitted to fda in accord with applicable regulations ¿ and as indicated by terumo cardiovascular systems in the initial report submitted to the fda on november 11, 2019.Upon further investigation of the reported event, the following information is new and/or changed: g4 (date received by manufacturer) g7 (indication that this is a follow-up report) h2 (follow-up due to additional information) h6 (identification of evaluation codes (4119, 4114, 3221, 4315).Method code #1: 4119 - insufficient information available method code #2: 4114 - device not returned results code: 3221 - no findings available conclusions code: 4315 - cause not established.The affected sample was not returned for evaluation.However, pictures provided with the complaint confirmed the existence of white biological material.A root cause could not be determined as the lot number is unknown and the sample was not returned.There are potential patient conditions with different blood levels and combinations of triglycerides, high lipid concentrations and activated white cell levels due to inflammatory response that may have occurred and contributed to the event.It could also be the residual of a platelet/white cell, (white clot) event.All available information has been placed on file in quality management for appropriate tracking, trending, and follow-up.
|